抗凝治疗与“中度风险”心房颤动患者的卒中风险[CHADS2评分=1]：简化现实临床实践中的卒中风险评估和血栓预防 - Suppr

Suppr

超能文献

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

作者信息

Lip Gregory Y H

出版信息

Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2.

DOI:10.1160/TH10-01-0038

PMID:20135056

Abstract

摘要

相似文献

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2.

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.

Thromb Haemost. 2010 Apr;103(4):833-40. doi: 10.1160/TH09-10-0746. Epub 2010 Feb 2.

Atrial fibrillation and anticoagulation.

Med Health R I. 2001 Mar;84(3):96-7.

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

Stroke prevention in atrial fibrillation patients.

Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819.

[Anticoagulation therapy in paroxysmal atrial fibrillation].

Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):950-2.

[What anticoagulant therapy should be used for what form of atrial fibrillation?].

Dtsch Med Wochenschr. 2000 Apr 20;125 Suppl 1:S10-1.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Lakartidningen. 2008;105(37):2478-80.

Cardioembolic stroke: call for a multidisciplinary approach.

Cerebrovasc Dis. 2009;27 Suppl 1:82-7. doi: 10.1159/000200444. Epub 2009 Apr 3.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. doi: 10.1016/j.jacc.2007.07.076. Epub 2007 Nov 13.

引用本文的文献

Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis.

Am J Cardiovasc Drugs. 2024 Mar;24(2):255-271. doi: 10.1007/s40256-024-00628-6. Epub 2024 Feb 22.

Challenges of Anticoagulant Therapy in Atrial Fibrillation-Focus on Gastrointestinal Bleeding.

Int J Mol Sci. 2023 Apr 7;24(8):6879. doi: 10.3390/ijms24086879.

Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.

Ann Emerg Med. 2019 Dec;74(6):759-771. doi: 10.1016/j.annemergmed.2019.03.026. Epub 2019 May 9.

Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.

Neth Heart J. 2014 Feb;22(2):55-61. doi: 10.1007/s12471-013-0472-1.

Oral antiplatelet therapy in acute coronary syndromes: update 2012.

Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):79-86. doi: 10.1177/2048872612443345.

Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.

J Neurol. 2013 Aug;260(8):2046-51. doi: 10.1007/s00415-013-6939-6. Epub 2013 May 5.

Atrial fibrillation: its prevalence and risk factor profile in the German general population.

Dtsch Arztebl Int. 2012 Apr;109(16):293-9. doi: 10.3238/arztebl.2012.0293. Epub 2012 Apr 20.

Can we predict stroke in atrial fibrillation?

Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):21-7. doi: 10.1002/clc.20969.

Atrial fibrillation and vascular disease--a bad combination.

Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):15-20. doi: 10.1002/clc.20955.

Are family physicians using the CHADS₂score? Is it useful for assessing risk of stroke in patients with atrial fibrillation?

Can Fam Physician. 2011 Aug;57(8):e305-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

作者信息

Lip Gregory Y H

出版信息

Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2.

DOI:10.1160/TH10-01-0038

PMID:20135056

Abstract

摘要

相似文献

Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2.

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.

Thromb Haemost. 2010 Apr;103(4):833-40. doi: 10.1160/TH09-10-0746. Epub 2010 Feb 2.

Atrial fibrillation and anticoagulation.

Med Health R I. 2001 Mar;84(3):96-7.

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

Stroke prevention in atrial fibrillation patients.

Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819.

[Anticoagulation therapy in paroxysmal atrial fibrillation].

Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):950-2.

[What anticoagulant therapy should be used for what form of atrial fibrillation?].

Dtsch Med Wochenschr. 2000 Apr 20;125 Suppl 1:S10-1.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Lakartidningen. 2008;105(37):2478-80.

Cardioembolic stroke: call for a multidisciplinary approach.

Cerebrovasc Dis. 2009;27 Suppl 1:82-7. doi: 10.1159/000200444. Epub 2009 Apr 3.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. doi: 10.1016/j.jacc.2007.07.076. Epub 2007 Nov 13.

引用本文的文献

Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis.

Am J Cardiovasc Drugs. 2024 Mar;24(2):255-271. doi: 10.1007/s40256-024-00628-6. Epub 2024 Feb 22.

Challenges of Anticoagulant Therapy in Atrial Fibrillation-Focus on Gastrointestinal Bleeding.

Int J Mol Sci. 2023 Apr 7;24(8):6879. doi: 10.3390/ijms24086879.

Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.

Ann Emerg Med. 2019 Dec;74(6):759-771. doi: 10.1016/j.annemergmed.2019.03.026. Epub 2019 May 9.

Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.

Neth Heart J. 2014 Feb;22(2):55-61. doi: 10.1007/s12471-013-0472-1.

Oral antiplatelet therapy in acute coronary syndromes: update 2012.

Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):79-86. doi: 10.1177/2048872612443345.

Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.

J Neurol. 2013 Aug;260(8):2046-51. doi: 10.1007/s00415-013-6939-6. Epub 2013 May 5.

Atrial fibrillation: its prevalence and risk factor profile in the German general population.

Dtsch Arztebl Int. 2012 Apr;109(16):293-9. doi: 10.3238/arztebl.2012.0293. Epub 2012 Apr 20.

Can we predict stroke in atrial fibrillation?

Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):21-7. doi: 10.1002/clc.20969.

Atrial fibrillation and vascular disease--a bad combination.

Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):15-20. doi: 10.1002/clc.20955.

Are family physicians using the CHADS₂score? Is it useful for assessing risk of stroke in patients with atrial fibrillation?

Can Fam Physician. 2011 Aug;57(8):e305-9.